The Pharma Letter46m
AC Immune Phase II ACI-7104.056 success in Parkinson’s
Swiss clinical-stage biopharma AC Immune saw its shares gain 8% to $3.38 in US trading this morning, after it released ...
The Pharma Letter53m
Merck KGaA shares slip on cautious outlook
Germany’s Merck KGaA (MRK: DE) was trading 5% lower as Thursday’s trading day neared its end, after the company announced its ...